CVS Health, UnitedHealth Group and Cigna sued the Federal Trade Commission, claiming the agency's case against drug middlemen over high insulin prices in the U.S. is unconstitutional.

Louisiana’s attorney general accuses CVS and Caremark of using patient data to push legislation and inflating drug prices, ...

Cigna, UnitedHealth and CVS Caremark are calling Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners to either recuse themselves, or be removed from the agency’s lawsuit ...

CVS shares fell 1.6% in midday trading, while UnitedHealth and Cigna shares were down marginally. 3 CVS Health’s CVS Caremark, a defendant, described the FTC as being “simply wrong.” ...

CVS Health is pushing back against claims from Louisiana Attorney General Liz Murrill and Gov. Jeff Landry that the company engaged in deceptive, anticompetitive practices, calling ...

Cigna, UnitedHealth and CVS Caremark are calling Federal Trade Commission (FTC) Chair Lina Khan and two other commissioners to either recuse themselves, or be removed from the agency’s lawsuit ...

CVS Health is a company in transition, moving away from the old pharmacy chain to an integrated healthcare giant. Read more ...

CVS and Cigna have filed two separate lawsuits seeking to overturn Arkansas’ new law, ... CVS, for example, operates a major network of retail pharmacies along with its PBM Caremark.

CVS Health Corporation CVS and The Cigna Group CI shares trading lower Tuesday. ... CVS owns CVS Caremark and Cigna owns Express Scripts, both of which operate as pharmacy benefit managers (PBM).

CVS Health subsidiary CVS Caremark, Cigna's Express Scripts and UnitedHealth Group's OptumRx collectively hold 70% of the PBM market, according to the American Medical Association.

CVS Caremark identified GLP-1 drugs and Humira as points of contention, but the State Health Plan says that mischaracterizes the issues.